Regulation of β-adrenoceptors in a rat model of cardiac failure: Effect of perindopril

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 1, 1998, Pages 66-74

  Gu, X H ^a   Kompa, A R ^a   Summers, R J ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Adrenoceptor; Angiotensin converting enzyme inhibition; Autoradiography; Cardiac failure; Myocardial infarction; Perindopril

Indexed keywords

BETA ADRENERGIC RECEPTOR; ISOPRENALINE; PERINDOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HEART FAILURE; HEART INFARCTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AUTORADIOGRAPHY; BLOOD PRESSURE; BODY WEIGHT; DOWN-REGULATION; FEMALE; HEART FAILURE, CONGESTIVE; INDOLES; IODOCYANOPINDOLOL; MYOCARDIAL INFARCTION; MYOCARDIUM; ORGAN SIZE; PERINDOPRIL; PINDOLOL; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA;

EID: 0031747366     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199807000-00011     Document Type: Article

References (46)

1. 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 1991;43:203-42.
2. 1 receptor messenger RNA abundance in the failing human heart. J Clin Invest 1993;92:2737-45.
3. 2-adrenoceptors in different human heart diseases. Naunyn Schmiedebergs Arch Pharmacol 1991;343:217-20.
4. Warner AL, Bellah KL, Raya TE, Roeske WR, Goldman S. Effect of β-adrenergic blockade on papillary muscle function and the β-adrenergic receptor system in non-infarcted myocardium in compensated ischaemic left ventricular dysfunction. Circulation 1992;86:1584-95.
5. 1-adrenergic receptors in the failing human heart. Circulation 1993;87:454-63.
6. Dhalla NS, Dixon IMC, Suzuki S. Kaneko M, Kobayashi A, Beamish RE. Change in adrenergic receptors during the development of heart failure. Mol Cell Biochem 1992;114:91-5.
7. Killip T. Epidemiology of congestive heart failure. Am J Cardiol 1985;56:2-6A.
8. Pfeffer MA, Pfeffer JM, Fishbein MC, et al. Myocardial infarction size and ventricular function in rats. Circ Res 1979;44:503-12.
9. Fletcher RJ, Pfeffer JM, Pfeffer MA, Braunwald E. Left ventricular diastolic pressure-volume relations in rat with healed myocardial infarction: effect on systolic function. Circ Res 1981;49: 618-26.
10. Clozel J-P, Holck M, Osterrider W, Burkand W, Prada MD. Effects of chronic myocardial infarction on responsiveness to isoprenaline and the state of myocardial beta adrenoceptors in rats. Cardiovasc Res 1987;21:688-95.
11. Vleeming W, Van Der Wouw PA, De Biesebeek JD, Van Rooij HH, Wemer J, Porsius AJ. Density of β-adrenoceptors in rat heart and lymphocytes 48 hours and 7 days after acute myocardial infarction. Cardiovasc Res 1989;23:859-66.
12. Wijngaarden JV, Monnink HJ, Bartels H, et al. Captopril modifies the response of infarcted rat hearts to isoprenaline stimulation. J Cardiovasc Pharmacol 1992;19:741-7.
13. Litwin SE, Morgan JP. Captopril enhances intracellular calcium handling and β-adrenergic responsiveness of myocardium from rats with postinfarction failure. Circ Res 1992;71:797-807.
14. Maisel AS, Phillips C, Michel MC, Ziegler MG, Carter SM. Regulation of cardiac β-adrenergic receptors by captopril: implications for congestive heart failure. Circulation 1989;80:669-75.
15. Michel JB, Mercadier JJ, Galen FX, et al. Urinary cyclic guanosine monophosphate as an indicator of experimental congestive heart failure in rats. Cardiovasc Res 1990;24:946-52.
16. Michel JB, Lattion AL, Salzemann JL, et al. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res 1988;62:641-50.
17. Thollon C, Kreher P, Charlon V, Rossi A. Hypertrophy induced alteration of action potential and effects of the inhibition of angiotensin converting enzyme by perindopril in infarcted rat hearts. Cardiovasc Res 1989;23:224-30.
18. Howes LG, Hodsmann GP, Rowe PR, Sumithran E, Johnston CI. Cardiac 3,4-dihydroxyphenylethylene glycol (DHPG) and catecholamine levels during perindopril therapy of chronic left ventricular failure in rats. J Auton Pharmacol 1989;9:15-21.
19. Lechat P, Garnham SP, Desche P, Bounhoure JP. Efficacy and acceptability of perindopril in mild to moderate chronic congestive heart failure. Am Heart J 1993;126:798-806.
20. Chiba K, Moriyama S, Ishigai Y, Fukuzawa A, Irie K, Shibano T. Lack of correlation of hypotensive effects with prevention of cardiac hypertrphy by perindopril after ligation of rat coronary artery. Br J Pharmacol 1994;112:837-42.
21. Tsunoda K, Hodsman GP, Sumithran E, Johnston CI. Atrial natriuretic peptide in chronic heart failure in the rat: a correlation with ventricular dysfunction. Circ Res 1986;59:256-61.
22. Fishbein MC, Maclean D, Maroko PR. Experimental myocardial infarction in rat. Am J Pathol 1978;90:57-70.
23. Molenaar P, Canale E, Summers RJ. Autoradiographic localisation of beta-1 and beta-2 adrenoceptors in guinea pig atrium and regions of the conducting system. J Pharmacol Exp Ther 1987;241:1048-64.
24. Nerme V, Severne Y, Abrahamsson N, Vauquelin G. Endogenous noradrenaline masks beta-adrenergic receptors in rat heart membranes via tight agonist binding. Biochem Pharmacol 1985;34: 2917-22.
25. 2-adrenoceptors in guinea-pig atrioventricular conducting system. J. Mol Cell Cardiol 1990;22:483-95.
26. McPherson GA. A practical computer-based approach to the analysis of radioligand binding experiments. Comput Programs Biomed 1983;17:107-13.
27. Munson PJ, Rodbard D. Ligand: a versatile computerised approach for characterization of ligand-binding systems. Anal Biochem 1980;107:220-39.
28. Wallenstein S, Zucker CL, Fleiss JC. Some statistical methods useful in circulation research. Circ Res 1980;47:1-9.
29. 2-adrenergic receptors in tissue compartments of rat heart is not altered by sympathetic denervation. Circ Res 1993;73:943-51.
30. Matthews JM, Molenaar P, Summers RJ. β-Adrenoceptor subtypes in the atrioventricular conducting system and myocardium of spontaneously hypertensive rats: effects of angiotensin-converting enzyme inhibition by perindopril. J Cardiovasc Pharmacol 1994;23:691-7.
31. Steinberg SF, Pagnotta G, Pak E, Zhang HL, Boyden P. Changes in the beta-adrenergic receptor complex underly abnormalities in the isoproterenol responsiveness in myocytes from the epicardial border zone of the infarcted heart. Circulation 1993;88(suppl 4):I-571.
32. max and the transient outward current. Circulation 1992;85:1175-88.
33. Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978;41:233-43.
34. Musch TI, Zelis R. Norepinephrine response to exercise of rats with a chronic myocardial infarction. Med Sci Sports Exerc 1991;23:569-77.
35. Wolff AA, Hines DK, Karliner JS. Refined membrane preparations mask ischaemic fall in myocardial β-receptor density. Am J Physiol 1989;257:H1032-6.
36. Olivetti G, Capasso JM, Meggs LG, Sonnenblick EH, Anversa P. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res 1991;68:856-69.
37. Bellah K, Raya T, Litwin S, Golman S, Karliner J. Effect of captopril on the beta-adrenergic system in non-infarcted myocardium in the rat heart failure model. J Am Coll Cardiol 1991;17:133A.
38. 2+ current in single rat ventricular cells. Circ Res 1993;73: 286-300.
39. Bristow MR, Hershberger RE, Port JD, et al. β-Adrenergic pathway in nonfailing and failing human ventricular myocardium. Circulation 1990;82:I-12-25.
40. Anversa P, Beghi C, Kikkawa Y, Olivetti G. Myocardial infarction in rats: infarction size, myocyte hypertrophy and capillary growth. Circ Res 1986;58:26-37.
41. Richer C, Mulder P, Fornes P, Domergue V, Heudes D, Giudicelli JF. Long-term treatment with trandolapril opposes cardiac remodelling and prolongs survival after myocardial infarction in rats. J Cardiovasc Pharmacol 1992;20:147-56.
42. 1- and beta-adrenoceptors. Eur J Pharmacol 1980;67:115-8.
43. Konstam MA, Kronenberg MW, Rousseau MF, et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction: SOLVD (Studies Of Left Ventricular Dysfunction) Investigators. Circulation 1993;88: 2277-83.
44. Hirsch AT, Talseners CE, Smith AD, Schunkert H, Ingelfinger JR, Dzau VJ. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure. Circulation 1992;86:1566-74.
45. Linz W, Wiemer G, Gohlke A, Unger T, Scholkens BA. Cardioprotective effects by ramapril after ischemia and reperfusion in experimental studies. Z Kardiol 1994;83(suppl 4):53-6.
46. Goldsmith SR, Hasking GJ, Miller E. Angiotesin II and sympathetic activity in patients with congestive heart failure. J Am Coll Cardiol 1993;15:1107-13.